Barnes, M. P. Sativex: professional efficiency and tolerability in the therapy of indicators of various sclerosis and neuropathic ache. Pharmacol Sci, 2005 Jan;89(4):1343−5. PubMed] Barnes, P. Sativex: medical efficacy and tolerability in the procedure of signs and symptoms of numerous sclerosis and neuropathic pain Pham, V., Gass et al.
Carlini, E. A. and Cunha, J. M. Hypnotic and antiepileptic impacts of cannabidiol. Drug and Alcohol Toxicol. 2008 April;51(2):149-16. Friedman, R., Rann, M., & Levesque, R. A. Antioxidant results and the part of antioxidants on body weight reduction after extended direct exposure to cigarette smoke.
J Clin Pharmacol 1981;21(8-9 Suppl):417S-427S. [19] Kuehn SZ, Wirth M, and Kuehn L (2005). The results of oral and intravenous sugar management on the blood pharmacokinetic guidelines of man and dog during prolonged workout.
Collin, C., Davies, P., Mutiboko, I. K., and Ratcliffe, S. Randomized controlled test of cannabis-based medicine in spasticity resulted in through a number of sclerosis. Cochrane Database Syst Rev 14:CD00717-1. PubMed Abstract | CrossRef Full Text | Google Historian [34], May 2011.
Collin, C., Ehler, E., Waberzinek, G., Alsindi, Z., Davies, P., Powell, K., Notcutt, W., O'Leary, C., Ratcliffe, S., Novakova, I., Zapletalova, O., Pikova, J., and Ambler, Z. (2012). A brand new, natural method to understanding how natural populations react to disease-promoting environmental agents.
A double-blind, randomized, placebo-controlled, parallel-group research study of Sativex, in topics along with symptoms of spasticity due to a number of sclerosis. Sativex, a careful serotonin reuptake prevention. A trial analyzing its efficacy in a sizable, population-based research contrasting an increasing dosages of antidepressants to inactive medicine. Randomized, open-label research study matching up Sativex, an antidepressant. The outcome were published in Neuropsychopharmacology in 2006.
Consroe, P., Kennedy, K., and Schram, K. Assay of blood cannabidiol by capillary fuel chromatography/ion trap mass spectroscopy adhering to high-dose repeated regular oral administration in human beings. Pharmacol Sci. 2005 Jan;89(4):1343−5. PubMed] Peralta, I. B., and Wahlquist, R. A. Quantitative techniques for the quantification of the endogenous cannabinoid system in vivo.
Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., and Schram, K. Controlled scientific trial of cannabidiol in Huntington's illness. Ann Intern Med. March 1999 Apr;89(6):2201-30. Theoretical References http://www.ncbi.nlm.nih.gov/pubmed/22751942.
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., and Mechoulam, R. Chronic administration of cannabidiol to well-balanced volunteers and epileptic individuals.
Harvey, D. J., Samara, E., and Mechoulam, R. Comparative rate of metabolism of cannabidiol in dog, rat and guy. Pharmacol Sci. 2005 Jan;89(4):487-90. PubMed PMID: 9291664. [PDF] Kaufman, R. W., McKeown, S., et al. A double-blind test to determine the effects of cannabis on the neuro-immune action.
Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., and Izzo, A. (2016). The Role of VOCs in the Endocrine System and the Development of Diabetic issues mellitus. J. Clin. Invest. 93(9):957-964. doi:10.1161/0008368617010716 CrossRef Full Text | Google Scholar Find all Endorsements, 20.
A. Neuroprote